New Search  | View FolderView Folder  |  Preferences  |  Help
Basic SearchAdvanced SearchChoose Database
Wright State University Libraries
 Sign In to My EBSCOhost
Keyword Search Academic Search Premier Publications Subject Terms Indexes Cited References Image Collection
Prev 2 of 9 Next   Result List | Refine Search     PrintPrint  E-mailE-mail  SaveSave   Items added to the folder may be printed, e-mailed or saved from the View Folder screen.Folder is empty.
Formats:   CitationCitation  

Title: The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
Authors: Armamento-Villareal, Reina C.1
Napoli, Nicola1
Klug, Thomas2
Civitelli, Roberto1
Source: BONE; Sep2004, Vol. 35 Issue 3, p682-688, 7p
Document Type: Article
Subject Terms: *ESTROGEN
Author-Supplied Keywords: Osteoporosis
Bone densitometry
Language of Keywords: English; German
Abstract: We have previously demonstrated that estrogen metabolism is one of the determinants of bone density after menopause. Increased hydroxylation to relatively nonestrogenic metabolites 2-hydroxyestrone (2OHE<sub>1</sub>) and 2-methoxyestrone (2MeOE<sub>1</sub>) was associated with low bone mineral density (BMD), while increased hydroxylation to the potent 16α-hydroxyestrone (16αOHE<sub>1</sub>) and weakly estrogenic estriol (E<sub>3</sub>) was associated with higher BMD. In this study, we tested the hypothesis that response to estrogen–hormone replacement therapy (ERT/HRT) is also related to individual differences in estrogen metabolism. Urinary estrogen metabolites were measured in 310 postmenopausal women using ESTRAMET enzyme immunoassay kit. Of these, 163 were on HRT with conjugated equine estrogen (CEE) and medroxyprogesterone acetate (MPA, Premarin™ and Provera™) or ERT with conjugated equine estrogen alone (Premarin™), and 147 women not on ERT/HRT acted as comparison. Annual rates of BMD changes were calculated on a subset of 81 women on ERT/HRT who had more than one previous BMD measured by dual-energy X-ray absorptiometry (DEXA). Controlling for age, years since menopause (YSM), body mass index (BMI), waist to hip ratio, and smoking, we found that urinary estrogen metabolite levels were significantly higher in ERT/HRT-treated women compared to those not on ERT/HRT. Furthermore, women in the higher 2 tertiles of 2OHE<sub>1</sub> and 2OHE<sub>1</sub>/16áOHE<sub>1</sub> ratio had positive increments in BMD compared to those in the lowest tertile who lost bone while on ERT/HRT. Thus, women with estrogen metabolism favoring the 2-hydroxylation pathway respond favorably to ERT/HRT. [ABSTRACT FROM AUTHOR; Copyright 2004 Elsevier]
Author Affiliations: 1Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA
2Immuna Care Corporation, Bethlehem, PA 18015, USA
ISSN: 8756-3282
DOI: 10.1016/j.bone.2004.05.010
Accession Number: 14250381
Persistent link to this record:
Database: Academic Search Premier
View Links:

Formats:   CitationCitation  

©2005 EBSCO Publishing. Privacy Policy - Terms of Use - Copyright